Zentek Ltd. (NASDAQ:ZTEK - Get Free Report) saw a significant growth in short interest during the month of July. As of July 15th, there was short interest totaling 69,900 shares, agrowthof2,396.4% from the June 30th total of 2,800 shares. Based on an average daily trading volume, of 54,500 shares, the short-interest ratio is presently 1.3 days. Approximately0.1% of the company's stock are short sold. Approximately0.1% of the company's stock are short sold. Based on an average daily trading volume, of 54,500 shares, the short-interest ratio is presently 1.3 days.
Institutional Trading of Zentek
Several hedge funds and other institutional investors have recently modified their holdings of ZTEK. Anson Funds Management LP acquired a new position in Zentek during the fourth quarter worth approximately $145,000. Two Sigma Securities LLC acquired a new position in Zentek during the fourth quarter worth approximately $31,000. Finally, Scotia Capital Inc. increased its position in Zentek by 5.7% during the fourth quarter. Scotia Capital Inc. now owns 958,771 shares of the company's stock worth $867,000 after buying an additional 51,744 shares during the last quarter. Institutional investors and hedge funds own 0.77% of the company's stock.
Zentek Price Performance
Shares of ZTEK stock traded down $0.06 during trading hours on Friday, hitting $0.82. The company had a trading volume of 46,802 shares, compared to its average volume of 46,015. Zentek has a 12 month low of $0.50 and a 12 month high of $1.84. The firm has a market capitalization of $86.18 million, a price-to-earnings ratio of -13.72 and a beta of 0.46. The firm's fifty day moving average is $1.22 and its 200 day moving average is $1.19. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.00 and a current ratio of 1.25.
Zentek (NASDAQ:ZTEK - Get Free Report) last released its quarterly earnings data on Thursday, June 26th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $0.57 million during the quarter. Zentek had a negative net margin of 1,186.72% and a negative return on equity of 58.87%.
About Zentek
(
Get Free Report)
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Zentek, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zentek wasn't on the list.
While Zentek currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.